Transcranial magnetic stimulation enhances the specificity of multiple sclerosis diagnostic criteria: a critical narrative review
PeerJ · 2024
DOI: 10.7717/peerj.17155 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PeerJ, 2024. Verfasst von Nicholas J Snow und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada. Hauptthemen laut MEDLINE: Multiple Sclerosis, Neurodegenerative Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Multiple sclerosis (MS) is an immune-mediated neurodegenerative disease that involves attacks of inflammatory demyelination and axonal damage, with variable but continuous disability accumulation. Transcranial magnetic stimulation (TMS) is a noninvasive method to characterize conduction loss and axonal damage in the corticospinal tract. TMS as a technique provides indices of corticospinal tract function that may serve as putative MS biomarkers. To date, no reviews have directly addressed the diagnostic performance of TMS in MS. The authors aimed to conduct a critical narrative review on the diagnostic performance of TMS in MS.
Methods
The authors searched the Embase, PubMed, Scopus, and Web of Science databases for studies that reported the sensitivity and/or specificity of any reported TMS technique compared to established clinical MS diagnostic criteria. Studies were summarized and critically appraised for their quality and validity.
Results
Seventeen of 1,073 records were included for data extraction and critical appraisal. Markers of demyelination and axonal damage—most notably, central motor conduction time (CMCT)—were specific, but not sensitive, for MS. Thirteen (76%), two (12%), and two (12%) studies exhibited high, unclear, and low risk of bias, respectively. No study demonstrated validity for TMS techniques as diagnostic biomarkers in MS.
Conclusions
CMCT has the potential to: (1) enhance the specificity of clinical MS diagnostic criteria by “ruling in” true-positives, or (2) revise a diagnosis from relapsing to progressive forms of MS. However, there is presently insufficient high-quality evidence to recommend any TMS technique in the diagnostic algorithm for MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada.
- Faculty of Health Sciences, Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada.
- Neuromodulation Research Clinic, The Royal's Institute of Mental Health Research, Ottawa, ON, Canada.
- Département de Psychoéducation et de Psychologie, Université du Québec en Outaouais, Gatineau, QC, Canada.
ORCID-Profile: Nicholas J Snow, Arthur R Chaves
Zitieren
APA
Snow, N. J., Murphy, H. M., Chaves, A. R., Moore, C. S., & Ploughman, M. (2024). Transcranial magnetic stimulation enhances the specificity of multiple sclerosis diagnostic criteria: a critical narrative review. PeerJ. https://doi.org/10.7717/peerj.17155
Vancouver
Snow NJ, Murphy HM, Chaves AR, Moore CS, Ploughman M. Transcranial magnetic stimulation enhances the specificity of multiple sclerosis diagnostic criteria: a critical narrative review. PeerJ. 2024. doi:10.7717/peerj.17155
BibTeX
@article{Snow2024,
author = {Snow, Nicholas J and Murphy, Hannah M and Chaves, Arthur R and Moore, Craig S and Ploughman, Michelle},
title = {Transcranial magnetic stimulation enhances the specificity of multiple sclerosis diagnostic criteria: a critical narrative review},
journal = {PeerJ},
year = {2024},
doi = {10.7717/peerj.17155}
}
EUVIMED